MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$692K
Net Income
-$31,849K
Net Profit Margin
-4602.46%
EPS
-$0.07
Unit: Thousand (K) dollars
Revenue Breakdown
Net product and licensing revenu...
Royalties and other revenue
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
692
21,102
5,493
14,182
Cost of sales
39
108
201
10
Research and development
17,443
12,756
11,314
18,757
Selling, general and administrative, including stock-based compensation of 1,952, 1,575, 3,661, and 3,044 respectively
9,750
9,234
8,759
7,602
Total operating expenses
27,232
22,098
20,274
26,369
(loss) income from operations
-26,540
-996
-14,781
-12,187
Interest and other expense
2,609
1,590
2,031
2,155
Interest and other income
1,723
1,543
1,283
1,573
Gain (loss) on extinguishment of debt
-4,349
-
-
-
Net loss
-31,775
-1,043
-15,529
-12,769
Unrealized gain on investments
-74
-160
1
43
Comprehensive (loss) income
-31,849
-1,203
-15,528
-12,726
Basic EPS
-0.07
0
-0.043
-0.04
Diluted EPS
-0.07
0
-0.043
-0.04
Basic Average Shares
437,653,000
400,240,000
363,446,000
363,399,000
Diluted Average Shares
437,653,000
400,240,000
363,170,000
363,399,000
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
LXRX Income Statement Sankey Diagram
Sankey diagram visualizing LXRX income statement for the period
Comprehensive (loss) income
-$31,849K
(-1091.25%β Y/Y)
Net loss
-$31,775K
(-1077.09%β Y/Y)
Unrealized gain on
investments
-$74K
(-89.74%β Y/Y)
Interest and other income
$1,723K
(-6.05%β Y/Y)
Net product and
licensing...
$680K
(-48.56%β Y/Y)
Royalties and other
revenue
$12K
(loss) income from
operations
-$26,540K
(-810.39%β Y/Y)
Gain (loss) on
extinguishment of debt
-$4,349K
Interest and other
expense
$2,609K
(12.55%β Y/Y)
Total revenues
$692K
(-97.60%β Y/Y)
Total operating
expenses
$27,232K
(8.36%β Y/Y)
Research and development
$17,443K
(10.77%β Y/Y)
Selling, general and
administrative, including...
$9,750K
(4.28%β Y/Y)
Cost of sales
$39K
(18.18%β Y/Y)
Buy us a coffee
LEXICON PHARMACEUTICALS, INC. (LXRX)
LEXICON PHARMACEUTICALS, INC. (LXRX)